Salvatore Thomas Butera is CEO - Volition Veterinary of VOLITIONRX LTD. Currently has a direct ownership of 230,750 shares of VNRX, which is worth approximately $140,757. The most recent transaction as insider was on Jun 01, 2024, when has been sold 31,256 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 231K
7.33% 3M change
276.12% 12M change
Total Value Held $140,757

Salvatore Thomas Butera Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2024
BUY
Grant, award, or other acquisition
-
31,256 Added 11.93%
230,750 Common Stock
May 01 2024
SELL
Payment of exercise price or tax liability
$13,488 $0.87 p/Share
15,504 Reduced 7.21%
199,494 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
36,125 Added 14.39%
214,998 Common Stock
Dec 18 2023
BUY
Open market or private purchase
$8,300 $0.83 p/Share
10,000 Added 9.14%
99,350 Common Stock
Dec 15 2023
BUY
Open market or private purchase
$7,700 $0.77 p/Share
10,000 Added 10.07%
89,350 Common Stock
Nov 16 2023
BUY
Open market or private purchase
$8,100 $0.81 p/Share
10,000 Added 11.19%
79,350 Common Stock
Oct 04 2023
SELL
Payment of exercise price or tax liability
$3,967 $0.68 p/Share
5,834 Reduced 3.16%
178,873 Common Stock
Aug 16 2023
BUY
Open market or private purchase
$9,680 $1.21 p/Share
8,000 Added 10.34%
69,350 Common Stock
Jul 05 2023
BUY
Grant, award, or other acquisition
-
28,800 Added 13.49%
184,707 Common Stock
Jun 02 2023
BUY
Open market or private purchase
$15,900 $1.59 p/Share
10,000 Added 14.02%
61,350 Common Stock
May 01 2023
SELL
Payment of exercise price or tax liability
$23,869 $1.67 p/Share
14,293 Reduced 8.4%
155,907 Common Stock
Jan 12 2023
BUY
Grant, award, or other acquisition
-
24,000 Added 12.36%
170,200 Common Stock
Dec 19 2022
BUY
Open market or private purchase
$11,350 $2.27 p/Share
5,000 Added 8.87%
51,350 Common Stock
Dec 12 2022
BUY
Open market or private purchase
$9,091 $2.09 p/Share
4,350 Added 8.58%
46,350 Common Stock
Nov 28 2022
BUY
Open market or private purchase
$11,050 $2.21 p/Share
5,000 Added 10.64%
42,000 Common Stock
Oct 13 2022
BUY
Grant, award, or other acquisition
-
11,200 Added 7.12%
146,200 Common Stock
Aug 23 2022
BUY
Open market or private purchase
$8,000 $1.6 p/Share
5,000 Added 2.94%
165,000 Common Stock
Aug 22 2022
BUY
Open market or private purchase
$8,200 $1.64 p/Share
5,000 Added 3.03%
160,000 Common Stock
Jun 16 2022
BUY
Open market or private purchase
$20,500 $2.05 p/Share
10,000 Added 6.06%
155,000 Common Stock
May 01 2022
SELL
Payment of exercise price or tax liability
$41,850 $2.79 p/Share
15,000 Reduced 9.38%
145,000 Common Stock
Nov 16 2021
BUY
Open market or private purchase
$40,200 $4.02 p/Share
10,000 Added 50.0%
10,000 Common Stock
May 01 2021
BUY
Grant, award, or other acquisition
-
150,000 Added 50.0%
150,000 Common Stock
Mar 25 2021
SELL
Sale (or disposition) back to the issuer
-
15,000 Reduced 100.0%
0 Common Stock
Dec 01 2020
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock
STB

Salvatore Thomas Butera

CEO - Volition Veterinary
Henderson, NV

Track Institutional and Insider Activities on VNRX

Follow VOLITIONRX LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX